Le Lézard
Classified in: Health
Subjects: LEG, POL, VET, DEI

Wounded Warrior Project Testifies Before Senate and House Veterans' Affairs Committees on Toxic Exposure Legislation

WASHINGTON, May 5, 2021 /PRNewswire/ -- Wounded Warrior Project® (WWP) government affairs specialist Aleks Morosky recently testified before the Senate and House Committees on Veterans' Affairs, encouraging Congress to take action on toxic exposure legislation. The health issues caused by burn pits and other toxic chemicals remain a critical issue facing post-9/11 wounded veterans ? and a top legislative priority for WWP.

"Wounded Warrior Project believes that veterans of all eras who suffered toxic exposures deserve access to lifesaving health care and a system that requires VA to respond to scientific data in a timely, transparent manner," Morosky said. "We're pleased with the legislation that has been introduced to reform these problems. However, time is of the essence; these warriors are sick, and some are dying, waiting for the care they have earned. We call upon Congress to pass these important bills without delay." 

Read WWP's list of recommendations to the House and Senate Veterans' Affairs Committees 

WWP is supporting complementary pieces of legislation that will reform existing policies and improve access to care and eligibility criteria, including:

Collectively, these pieces of legislation will accomplish the following objectives:

Learn more about WWP's legislative priorities.

About Wounded Warrior Project

Since 2003, Wounded Warrior Project® (WWP) has been meeting the growing needs of warriors, their families and caregivers ? helping them achieve their highest ambition. Learn more.



SOURCE Wounded Warrior Project

These press releases may also interest you

at 02:05
Following months of collaborative development work, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO's...

at 02:00
- The Obstetric Safe Surgery (OSS) Project in Kenya is funded by Johnson & Johnson and to date has been implemented by Jhpiego as the lead organization, in collaboration with County and National Ministries of Health and professional associations. -...

at 02:00
Gedeon Richter Plc. ("Richter") and Hikma Pharmaceuticals PLC ("Hikma") today announced that they have entered into an exclusive license agreement to commercialise Richter's denosumab, comprising two biosimilar products referencing Prolia® and...

at 01:35
QIAGEN and Denovo Biopharma LLC today announced a collaboration to develop a blood-based companion diagnostic (CDx) test to identify patients expressing Denovo Genomic Marker 1 (DGM1TM) who are likely to respond to Denovo's investigational cancer...

at 00:55
Prestige BioPharma Ltd. (KRX: 950210) and Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred to as "Dr. Reddy's") today announced that the two companies have entered into a binding agreement for...

8 déc 2021
Chalice Brands Ltd. ("Chalice" or the "Company"), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, is pleased to announce it has successfully completed an agreement (the...

News published on 5 may 2021 at 15:55 and distributed by: